720 related articles for article (PubMed ID: 9611100)
1. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
[TBL] [Abstract][Full Text] [Related]
2. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
3. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland tumors among atomic bomb survivors, 1950-1987.
Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
[TBL] [Abstract][Full Text] [Related]
7. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
[TBL] [Abstract][Full Text] [Related]
9. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
[TBL] [Abstract][Full Text] [Related]
10. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995.
Yonehara S; Brenner AV; Kishikawa M; Inskip PD; Preston DL; Ron E; Mabuchi K; Tokuoka S
Cancer; 2004 Oct; 101(7):1644-54. PubMed ID: 15378499
[TBL] [Abstract][Full Text] [Related]
11. Stable chromosome aberrations among A-bomb survivors: an update.
Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
13. Profiles of non-cancer diseases in atomic bomb survivors.
Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions.
Yamada M; Izumi S
Soc Psychiatry Psychiatr Epidemiol; 2002 Sep; 37(9):409-15. PubMed ID: 12242616
[TBL] [Abstract][Full Text] [Related]
16. Radiation and cancer risk in atomic-bomb survivors.
Kodama K; Ozasa K; Okubo T
J Radiol Prot; 2012 Mar; 32(1):N51-4. PubMed ID: 22394591
[TBL] [Abstract][Full Text] [Related]
17. Leukemia: lessons from the Japanese experience.
Finch SC
Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
[TBL] [Abstract][Full Text] [Related]
18. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
Otake M; Schull WJ
Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
[TBL] [Abstract][Full Text] [Related]
19. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
[TBL] [Abstract][Full Text] [Related]
20. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors.
Wong FL; Yamada M; Sasaki H; Kodama K; Hosoda Y
Radiat Res; 1999 Jun; 151(6):736-46. PubMed ID: 10360794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
